Showing results (671-680 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
The Lancet. Neurology|August 10, 2019
Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant dataTom J Moullaali, Xia Wang, Reneé H Martin, et al.
The Lancet. Neurology|September 19, 2019
Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort studyEwout W Steyerberg, Eveline Wiegers, Charlie Sewalt, et al.
The Lancet. Neurology|December 23, 2021
Sleep apnoea and ischaemic stroke: current knowledge and future directionsSébastien Baillieul, Martijn Dekkers, Anne-Kathrin Brill, et al.
The Lancet. Neurology|June 10, 2008
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic studyMary M Hulihan, Lianna Ishihara-Paul, Jennifer Kachergus, et al.
The Lancet. Neurology|March 13, 2014
Long-term, serial screening for intracranial aneurysms in individuals with a family history of aneurysmal subarachnoid haemorrhage: a cohort studyA Stijntje E Bor, Gabriel J E Rinkel, Jeroen van Norden, et al.
The Lancet. Neurology|October 20, 2018
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trialChristopher Grunseich, Ram Miller, Therese Swan, et al.
The Lancet. Neurology|June 3, 2008
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trialClaudia Trenkwalder, Heike Benes, Werner Poewe, et al.
The Lancet. Neurology|February 22, 2014
Targeting the β secretase BACE1 for Alzheimer's disease therapyRiqiang Yan, Robert Vassar
The Lancet. Neurology|October 13, 2009
Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trialJoëlle Micallef, Shahram Attarian, Odile Dubourg, et al.
Pageof 199